These data are in contrast with the literature and in particular with the large study on 797 NSCLC patients conducted by Donnem et al. (11, 19) where IT CD8+ lymphocytes correlated positively with survival and this correlation remained significant across different stages (26). Here, CD8A is linked to non-small cell lung carcinoma.